Effectiveness of group-delivered cognitive behavioural therapy for insomnia in primary care: a pragmatic, multicentre randomised controlled trial

被引:1
作者
Hrozanova, Maria [1 ]
Skarpsno, Eivind Schjelderup [1 ,2 ]
Follestad, Turid [1 ]
Kallestad, Havard [3 ,4 ]
Pallesen, Stale [5 ,6 ]
Nordstoga, Anne Lovise [7 ]
Mollerlokken, Nina Elise [8 ]
Ronning, Astrid Sletteng [8 ]
Meisingset, Ingebrigt [1 ,9 ]
机构
[1] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway
[2] St Olavs Hosp, Dept Neurol & Clin Neurophysiol, Trondheim, Norway
[3] Norwegian Univ Sci & Technol, Dept Mental Hlth, Trondheim, Norway
[4] St Olavs Hosp, Dept Mental Hlth Care, Trondheim, Norway
[5] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, Bergen, Norway
[6] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway
[7] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway
[8] Trondheim Municipal, Unit Hlth Living Learning & Mastery, Trondheim, Norway
[9] Unit Physiotherapy Serv, Trondheim, Norway
关键词
Insomnia; Insomnia treatment; Cognitive-behavioural therapy for insomnia; CBT-I; Primary care; Randomized controlled trial; Group-delivered treatment; Treatment effectiveness; SLEEP; METAANALYSIS; SEVERITY; OUTCOMES; ADULTS;
D O I
10.1016/j.sleep.2025.106495
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Insomnia is a prevalent disorder in the general population. Group delivery increases access to the treatment of choice for insomnia, cognitive-behavioural therapy for insomnia (CBT-I). The aim of this pragmatic randomized controlled trial was to investigate the effectiveness of low-threshold group-delivered CBT-I implemented in Norwegian primary care. The trial was registered in the ISRCTN registry (ISRCTN16185698), and conducted across 26 Healthy Life Centres. Inclusion criteria were age >= 18 years and insomnia symptoms with a significant impact (Insomnia Severity Index (ISI) >= 12). Eligible participants were randomized to group-delivered CBT-I or to a waiting list according to a 2:1 ratio. The intervention consisted of four 2-h sessions over 4 weeks, with 5-15 participants per group. Primary outcome was self-reported insomnia severity at 3-months follow-up, measured by the ISI. Participants were not blinded to group assignment, but those responsible for analyses and interpretation of the results were. In total, 308 participants were randomly allocated to group-delivered CBT-I (n = 181) or waiting list (n = 127). The mean difference in ISI score between groups at 3-months follow-up was-3.4 (95% CI: 4.3 to-2.5), favoring the group-delivered CBT-I. Of those receiving group-delivered CBT-I, 51 (33.6 %) reported a clinically relevant improvement in insomnia severity (i.e., >= 8 points on ISI), compared to 15(13.2 %) on the waiting list (OR 3.4, 95 % CI: 1.7 to 6.8). Thus, group-delivered CBT-I reduced insomnia severity at 3months follow-up for adults with insomnia. Group-delivered CBT-I offered at Healthy Life Centres is a suitable low-threshold treatment for insomnia in primary care.
引用
收藏
页数:10
相关论文
共 45 条
[41]   Different ways to estimate treatment effects in randomised controlled trials [J].
Twisk, J. ;
Bosman, L. ;
Hoekstra, T. ;
Rijnhart, J. ;
Welten, M. ;
Heymans, M. .
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 10 :80-85
[42]   Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis [J].
van Straten, Annemieke ;
van der Zweerde, Tanja ;
Kleiboer, Annet ;
Cuijpers, Pim ;
Morin, Charles M. ;
Lancee, Jaap .
SLEEP MEDICINE REVIEWS, 2018, 38 :3-16
[43]  
Vedaa O, 2020, LANCET DIGIT HEALTH, V2, pE397, DOI 10.1016/S2589-7500(20)30135-7
[44]   Insomnia is a risk factor for spreading of chronic pain: A Swedish longitudinal population study (SwePain) [J].
Wiklund, Tobias ;
Gerdle, Bjorn ;
Linton, Steven J. ;
Dragioti, Elena ;
Larsson, Britt .
EUROPEAN JOURNAL OF PAIN, 2020, 24 (07) :1348-1356
[45]   Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies [J].
Wu, T. T. ;
Zou, Y. L. ;
Xu, K. D. ;
Jiang, X. R. ;
Zhou, M. M. ;
Zhang, S. B. ;
Song, C. H. .
PUBLIC HEALTH, 2023, 215 :66-74